Collection

Vivaldi study: results

Results for the Vivaldi study for antibody and cellular immune responses to coronavirus (COVID-19) in approximately 340 care homes.

Updates to this page

Published 28 May 2021
Last updated 27 January 2023 + show all updates
  1. Added Privacy notice.

  2. Added Vivaldi 3: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes.

  3. Added Vivaldi 3: coronavirus (COVID-19) antibody and cellular immune response in care homes study report.

  4. First published.